Teva Stock Highest Level: Why It Could Soar Further
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
This guide examines ETFs that tend to minimize taxes in taxable accounts, helping you identify tax-efficient options. Learn how to apply these picks to improve after-tax returns.
22,220 articlesTeva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
As May 2026 unfolds, smart investors are looking for durable growth in healthcare. Here are three standout names, why...
Brokerage consolidations are shifting leverage toward agents as new split and autonomy models emerge. This report exa...
Nexgel's Q1 2026 earnings reveal the early trajectory of the year. This analysis breaks down the numbers, explains th...
Brown University economist Mark Blyth outlines how a new Fed chair could steer policy through inflation and growth he...
The trillion-dollar club is expanding, and a few ahead-of-the-curve signals can help you spot the next member. This g...
Oil flows are shifting as the Strait of Hormuz crisis intensifies, pushing the U.S. to export crude to Australia. Mar...
Bitcoin sits in a delicate consolidation phase as traders grapple with potentially game-changing levels. On-chain dat...
KeyBanc boosts Okta's target to $103 from $95, citing a brighter security spending outlook and the central role of id...
Caterpillar's backlog hits a record, fueling optimism that shares could approach $1,000 by 2027. Analysts weigh upsid...
XRP traders are watching a narrow price corridor as Ripple eyes a breakout. With critical support near $1.30 and resi...
As millions of Americans reach age 65, a pivotal six-month window shapes long-term health coverage costs. The medicar...